98
Views
14
CrossRef citations to date
0
Altmetric
Brief Report

The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia

, , , , &
Pages 1677-1682 | Accepted 26 Aug 2005, Published online: 20 Sep 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Francis Vekeman, R. Scott McKenzie, Brahim K. Bookhart, François Laliberté, Mei Sheng Duh, Catherine Tak Piech & Patrick Lefebvre. (2009) Drug utilisation and cost considerations of erythropoiesis stimulating agents in oncology patients receiving chemotherapy: observations from a large managed-care database. Journal of Medical Economics 12:1, pages 1-8.
Read now
Frank J Papatheofanis. (2007) Comparative costs of treatment with epoetin alfa and darbepoetin alfa for anemia in the oncology and nephrology settings. Expert Review of Pharmacoeconomics & Outcomes Research 7:1, pages 59-73.
Read now

Articles from other publishers (12)

Louise Crathorne, Nicola Huxley, Marcela Haasova, Tristan Snowsill, Tracey Jones-Hughes, Martin Hoyle, Simon Briscoe, Helen Coelho, Linda Long, Antonieta Medina-Lara, Ruben Mujica-Mota, Mark Napier & Chris Hyde. (2016) The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model. Health Technology Assessment 20:13, pages 1-588.
Crossref
Ozgur Tunceli, Robert A Bailey, Judith J Stephenson & Joseph Singer. (2012) Propensity score matched assessment of treatment patterns and cost of erythropoiesis stimulating agent treatment in patients with cancer receiving myelosuppressive chemotherapy. Journal of Oncology Pharmacy Practice 19:4, pages 305-314.
Crossref
Carlo Lucioni, S. Mazzi, C. Brovero & M. Gozzo. (2013) Una valutazione economica degli agenti stimolanti l’eritropoiesi nel trattamento dell’anemia indotta da chemioterapia in ItaliaEconomic evaluation of erythropoiesis stimulating agents for the treatment of chemotherapy-induced anemia in Italy. Giornale Italiano di Health Technology Assessment 4:1, pages 7-15.
Crossref
R. Ravasio, M. D’Orsi, G. F. Zuccotti, A. Girlanda, D. Cantù, C. Buffa & M. De Petris. (2013) Analisi dei costi degli agenti stimolanti l’eritropoiesi nel trattamento dell’anemia indotta da chemioterapia: l’esperienza della ASL della provincia di AlessandriaCost minimization analysis of erythropoietin receptor agonists in the treatment of cancer patients with anemia: the experience of the Local Health Unit of Alessandria. PharmacoEconomics Italian Research Articles 12:3, pages 175-182.
Crossref
Matthew S. McKinney & Jeffrey Crawford. 2011. Practical Geriatric Oncology. Practical Geriatric Oncology 338 350 .
Roberto Ravasio. (2013) Valutazione economica di epoetina alfa nel trattamento dell’anemia indotta da chemioterapia: una revisione sistematica della letteratura. Giornale Italiano di Health Technology Assessment 2:1, pages 37-45.
Crossref
R. Ravasio, G. Bernardo, C. Cerra & P. Fratino. (2013) Analisi di minimizzazione dei costi degli agenti stimolanti l’eritropoiesi nel trattamento dell’anemia indotta da chemioterapiaCost minimization analysis of erythropoietin receptor agonists in the treatment of cancer patients with anemia. PharmacoEconomics Italian Research Articles 11:1, pages 15-23.
Crossref
José Luis Pontón Sivillá, Evaristo Feliu Frasnedo, Pilar Modamio Charles, Eduardo L. Mariño Hernández, Albert Font Pous, Clara Lezcano Rubio, José María Ribera Santasusana & Xavier Bonafont Pujol. (2008) Estudio de la efectividad de tres esquemas de administración de factores estimuladores de la eritropoyesis en pacientes con anemia asociada a quimioterapia por una neoplasia sólida o hematologica. Medicina Clínica 131:12, pages 447-451.
Crossref
Mei Sheng Duh, Jennifer R Weiner, Leigh Ann White, Patrick Lefebvre & Paul E Greenberg. (2008) Management of Anaemia. PharmacoEconomics 26:2, pages 99-120.
Crossref
Harminder Sikand, Adam Decter, Tina Greco, Sue H Watson, Yoon Jun KangSamir H ModyCatherine Tak PiechMei Sheng DuhAyesha Naeem. (2016) Cost Analytic Model to Determine the Least Costly Inpatient Erythropoiesis Stimulating Therapy Regimen. Annals of Pharmacotherapy 42:1, pages 16-23.
Crossref
Francis VekemanR. Scott McKenzie, Patrick Lefebvre, Sue H. Watson, Samir H. Mody, Catherine Tak Piech & Mei Sheng Duh. (2007) Dose and cost comparison of erythropoietic agents in the inpatient hospital setting. American Journal of Health-System Pharmacy 64:18, pages 1943-1949.
Crossref
M Asif A Siddiqui & Gillian M Keating. (2006) Darbepoetin??Alfa. Drugs 66:7, pages 997-1012.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.